Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis
Conclusions: Our results demonstrated that TREM1 could be used as a novel immunotherapy target for glioma patients.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Brain Tumor | Cancer | Cancer & Oncology | China Health | Databases & Libraries | Genetics | Glioma | Immunotherapy